Non-peptide GLP-1 agonists
US6927214B1 · kind B1 · utility
4Cited by
4References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2000 |
| Grant date | Aug 9, 2005 |
| Priority date | — |
| Expiry date | Jan 14, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel non-peptide GLP-1 agonists, pharmaceutical compositions comprising them, use of the non-peptide GLP-1 agonists for the preparation of pharmaceutical compositions and methods for the treatment and/or prevention of disorders and diseases wherein an activation of the human GLP-1 receptor is beneficial, especially metabolic disorders such as IGT, Type 1 diabetes, Type 2 diabetes and obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.